Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Effect of Proteasome Subunit Beta Type 1 P11A Polymorphism on the Survival of Multiple Myeloma Patients Treated with First Line Bortezomib Based Chemotherapy

Gergely Varga, MD, Gabor Mikala, MD PhD, Gergely Szombath, MD, Katalin Balassa, MD, Katalin Piroska Kiss, MD, Attila Tordai, PhD DSc, Hajnalka Andrikovics, MD PhD, Tamas Masszi, MD PhD

Blood (2015) 126 (23): 1765.

https://doi.org/10.1182/blood.V126.23.1765.1765

Published: 2015

Journal Articles

Extramedullary Myeloid Sarcoma With Eosinophilia and FIP1L1-Pdgfra Rearrangement: Complete Cytogenetic Response To Imatinib Therapy

Zoltan Matrai, MD, PhD, Hajnalka Andrikovics, MD, PhD, Judit Csomor, MD, PhD, Botond Timár, MD, PhD, András Kozma, MD, Attila Tordai, MD, PhD, Tamas Masszi, MD, PhD

Blood (2013) 122 (21): 5033.

https://doi.org/10.1182/blood.V122.21.5033.5033

Published: 2013

Journal Articles

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease.

Hajnalka Andrikovics, MD, PhD, Nora Meggyesi, Aniko Szilvasi, Julia Tamaska, MD, Gabriella Halm, MD, Sandor Lueff, MD, Sarolta Nahajevszky, MD, Miklos Egyed, MD, PhD, Judit Varkonyi, MD, PhD, Gabor Mikala, MD, PhD, Andrea Sipos, MD, Attila Tordai, MD, PhD, Tamas Masszi, MD, PhD

Blood (2006) 108 (11): 4904.

https://doi.org/10.1182/blood.V108.11.4904.4904

Published: 2006

Journal Articles

Homozygosity for a novel nonsense mutation (G66X) of the HJV gene causes severe juvenile hemochromatosis with fatal cardiomyopathy

András Jánosi, Hajnalka Andrikovics, Katalin Vas, András Bors, Márta Hubay, Zoltán Sápi, Attila Tordai

Blood (2005) 105 (1): 432.

https://doi.org/10.1182/blood-2004-09-3508

Published: 2005

Journal Articles

Prognostic Significance of FLT3 ITD and Asp835 Mutations in Patients with Acute Myeloid Leukemia (AML) - a Single Institution Experience.

Sarolta Nahajevszky, Hajnalka Andrikovics, Nora Lovas, Attila Tordai, Anna Poros

Blood (2004) 104 (11): 4424.

https://doi.org/10.1182/blood.V104.11.4424.4424

Published: 2004

NARROW

The Effect of Proteasome Subunit Beta Type 1 P11A Polymorphism on the Survival of Multiple Myeloma Patients Treated with First Line Bortezomib Based Chemotherapy

Extramedullary Myeloid Sarcoma With Eosinophilia and FIP1L1-Pdgfra Rearrangement: Complete Cytogenetic Response To Imatinib Therapy

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease.

Homozygosity for a novel nonsense mutation (G66X) of the HJV gene causes severe juvenile hemochromatosis with fatal cardiomyopathy

Prognostic Significance of FLT3 ITD and Asp835 Mutations in Patients with Acute Myeloid Leukemia (AML) - a Single Institution Experience.

Email alerts

ASH Publications

American Society of Hematology

The Effect of Proteasome Subunit Beta Type 1 P11A Polymorphism on the Survival of Multiple Myeloma Patients Treated with First Line Bortezomib Based Chemotherapy

Extramedullary Myeloid Sarcoma With Eosinophilia and FIP1L1-Pdgfra Rearrangement: Complete Cytogenetic Response To Imatinib Therapy

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease.

Homozygosity for a novel nonsense mutation (G66X) of the HJV gene causes severe juvenile hemochromatosis with fatal cardiomyopathy

Prognostic Significance of FLT3 ITD and Asp835 Mutations in Patients with Acute Myeloid Leukemia (AML) - a Single Institution Experience.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only